UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: November 14, 2024
Accession Number: 0001213900-24-097459
Submission Type: POS AM
CIK: 0001766140
Company Name: Unicycive Therapeutics, Inc.
File Number: 333-266890